Mereo BioPharma Group PLC (MREO)
3.20
-0.07
(-2.14%)
USD |
NASDAQ |
May 17, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Enterprise Value: 404.84M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 404.84M |
| May 16, 2024 | 414.66M |
| May 15, 2024 | 400.63M |
| May 14, 2024 | 371.17M |
| May 13, 2024 | 372.58M |
| May 10, 2024 | 380.99M |
| May 09, 2024 | 414.66M |
| May 08, 2024 | 390.81M |
| May 07, 2024 | 378.19M |
| May 06, 2024 | 390.81M |
| May 03, 2024 | 413.26M |
| May 02, 2024 | 392.21M |
| May 01, 2024 | 397.83M |
| April 30, 2024 | 383.80M |
| April 29, 2024 | 343.12M |
| April 26, 2024 | 340.31M |
| April 25, 2024 | 350.13M |
| April 24, 2024 | 345.92M |
| April 23, 2024 | 345.92M |
| April 22, 2024 | 347.33M |
| April 19, 2024 | 326.29M |
| April 18, 2024 | 327.69M |
| April 17, 2024 | 317.87M |
| April 16, 2024 | 333.30M |
| April 15, 2024 | 330.49M |
| Date | Value |
|---|---|
| April 12, 2024 | 337.50M |
| April 11, 2024 | 340.31M |
| April 10, 2024 | 368.36M |
| April 09, 2024 | 395.01M |
| April 08, 2024 | 400.63M |
| April 05, 2024 | 417.46M |
| April 04, 2024 | 413.25M |
| April 03, 2024 | 434.29M |
| April 02, 2024 | 430.08M |
| April 01, 2024 | 434.29M |
| March 28, 2024 | 419.63M |
| March 27, 2024 | 377.56M |
| March 26, 2024 | 370.54M |
| March 25, 2024 | 373.35M |
| March 22, 2024 | 374.75M |
| March 21, 2024 | 371.95M |
| March 20, 2024 | 391.58M |
| March 19, 2024 | 383.17M |
| March 18, 2024 | 390.18M |
| March 15, 2024 | 392.99M |
| March 14, 2024 | 397.19M |
| March 13, 2024 | 404.21M |
| March 12, 2024 | 447.69M |
| March 11, 2024 | 454.70M |
| March 08, 2024 | 458.91M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-69.32M
Minimum
May 11 2022
524.02M
Maximum
Jan 29 2024
133.57M
Average
94.89M
Median
Apr 27 2023
Enterprise Value Benchmarks
| Biodexa Pharmaceuticals Plc | -2.388M |
| NuCana PLC | -14.39M |
| TC BioPharm (Holdings) PLC | 0.4733M |
| Adaptimmune Therapeutics PLC | 140.02M |
| Autolus Therapeutics PLC | 927.85M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.951M |
| Total Expenses (Quarterly) | 9.423M |
| EPS Diluted (Quarterly) | -0.05 |